The genomic landscape of pediatric rheumatology disorders in the Middle East.

Autor: Fathalla BM; Rheumatology Department, Al Jalila Children's Specialty Hospital, Dubai, UAE., Alsarhan A; Pediatric Residency Program, Al Jalila Children's Specialty Hospital, Dubai, UAE., Afzal S; Oncology & Hematology Department, Al Jalila Children's Specialty Hospital, Dubai, UAE., El Naofal M; Al Jalila Genomics Center, Al Jalila Children's Specialty Hospital, Dubai, UAE., Abou Tayoun A; Al Jalila Genomics Center, Al Jalila Children's Specialty Hospital, Dubai, UAE.; Genetics Department, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.
Jazyk: angličtina
Zdroj: Human mutation [Hum Mutat] 2021 Apr; Vol. 42 (4), pp. e1-e14. Date of Electronic Publication: 2021 Feb 07.
DOI: 10.1002/humu.24165
Abstrakt: The landscape and clinical utility of comprehensive genomic investigations for a wide range of pediatric rheumatic disorders have not been fully characterized in the Middle East. Here, 71 pediatric patients, of diverse Arab origins, were clinically and genetically assessed for a spectrum of rheumatology-related diseases at the only dedicated tertiary children's hospital in the United Arab Emirates. Clinical genomic investigations included mainly (76%) next-generation sequencing-based gene panels and whole-exome sequencing, along with rapid sequencing in the intensive care unit and urgent setting. The overall positive yield was 46.5%, whereas dual diagnoses were made in two cases (3%). Although the majority (21/33, 64%) of positive findings involved the MEFV gene, the remaining (12/33, 36%) alterations were attributed to 11 other genes/loci. Copy number variants (CNVs) contributed substantially (5/33, 15.2%) to the overall diagnostic yield. Sequencing-based testing, specifically rapid sequencing, had a high positive rate and delivered timely results. Genetic findings guided clinical management plans and interventions in most cases (27/33, 81.8%). We highlight unique findings and provide additional evidence that heterozygous loss of function of the IFIH1 gene increases susceptibility to recurrent fevers. Our study provides new insights into the pathogenic variation landscape in pediatric rheumatic disorders.
(© 2021 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: